Influences of obese (ob/ob) and diabetes (db/db) genotype mutations on lumber vertebral radiological and morphometric indices: Skeletal deformation associated with dysregulated systemic glucometabolism

BMC Musculoskeletal Disorders

Volumn 7, Issue , 2006, Pages

  Burkemper, Katherine M ^a   Garris, David R ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE GROWTH; BONE MATURATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GENE EXPRESSION; GENE MUTATION; GENOTYPE; GROWTH RATE; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; LOW DRUG DOSE; LUMBAR SPINE; LUMBAR VERTEBRA; METABOLIC SYNDROME X; MISSENSE MUTATION; MORPHOMETRICS; MOUSE; MUTANT; NONHUMAN; OBESITY; ONSET AGE; RADIOLOGY; SKELETON MALFORMATION; ANIMAL; C57BL MOUSE; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOUSE MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; SPINE; SYNDROME;

ANIMALS; BONE DEVELOPMENT; DIABETES MELLITUS, TYPE 2; ESTRADIOL; FEMALE; GENOTYPE; GLUCOSE; LUMBAR VERTEBRAE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUTATION, MISSENSE; OBESITY; SPINE; SYNDROME;

EID: 33644762989     PISSN: 14712474     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-7-10     Document Type: Article

References (52)

1. Verhaeghe J, Oloumi G, van Herck E, van Bree R, Dequeker J, Einhorn T, Bouillon R: Effects of long-term diabetes and/or high-dose 17β-estradiol on bone formation, bone mineral density, and strength in ovariectomized rats. Bone 1997, 20:421-428.
2. Lu H, Kraut D, Gerstenfeld L, Graves D: Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocr 2003, 144:346-352.
3. Levin M, Boisseau V, Avioli L: Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N Engl J Med 1976, 294:241-245.
4. Balint E, Szabo P, Marshall C, Sprague S: Glucose-induced inhibition of in vitro bone mineralization. Bone 2001, 28:21-28.
5. Giacca A, Fassina A, Caviezel F, Cattaneo A, Caldirola G, Pozza G: Bone mineral density in diabetes mellitus. Bone 1988, 9:29-36.
6. Follak N, Kloting I, Wolf E, Merk H: Histomorphometric evaluation of the influence of the diabetic metabolic state on bone defect healing depending on the defect size in spontaneously diabetic BB/OK rats. Bone 2004, 35:144-152.
7. Maor G, Karieli E: The insulin-sensitive glucose transporter (GLUT4) is involved in early bone growth in control and diabetic mice, but is regulated through the insulin-like growth factor 1 receptor. Endocr 1999, 140:1841-1851.
8. Brown S, Sharpless J: Osteoporosis: an under-appreciated complication of diabetes. Clin Diabet 2004, 22:10-20.
9. Seeman E: Physiology of aging invited review: pathogenesis of osteoporosis. J Appl Physiol 2003, 95:2142-2151.
10. Suzuki K, Miyakoshi N, Tsuchida T, Kasukawa Y, Sato K, Itoi E: Effects of combined treatment of insulin and human parathyroid hormone (1-34) on cancellous bone mass and structure in streptozotocin-induced diabetic rats. Bone 2003, 33:108-114.
11. Auwerx J, Dequeker J, Bouillon R, Geusens P, Nijs J: Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus. Diabetes 1988, 37:8-12.
12. Ishida h, Seino Y, Taminato T, Usami M, Takeshita N, Seino Y, Tsutsumi C, Moriuchi S, Akiyama Y, Hara K, Imura H: Circulating levels and bone contents of bone γ-carboxyglutamic acid-containing protein are decreased in streptozotocin-induced diabetes. Diabetes 1988, 37:702-706.
13. Tintut Y, Morony S, Demer LL: Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterio, Thromb, Vasc Biol 2004, 24:154-162.
14. Glajchen N, Epstein S, Ismail F, Thomas S, Fallon M, Chakrabarti S: Bone mineral metabolism in experimental diabetes mellitus: osteocalcin as a measure of bone remodeling. Endocr 1988, 123:290-295.
15. Coleman D: Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978, 14:141-148.
16. Garris D: Variable onset determinants and consequences of diabetes (db/db) obesity mutation expression: adrenergic promotion of utero-ovarian dysfunction. Horm Metab Res 2004, 36:312-318.
17. Garris D, Garris B: Genomic modulation of diabetes (db/db) and obese (ob/ob) mutation-induced hypercytolipidemia: cytochemical basis of female reproductive tract involution. Cell Tiss Res 2004, 316:233-241.
18. Garris D, Novikova L, Garris B, Lau Y-S: Hypercytolipidemia-induced nuclear lipoapoptosis: cytochemical analysis and integrated review of hypogonadal, diabetes-obesity syndrome-induced female reproductive axis disruption. Metab Syndr Rel Dis 2005, 3:198-209.
19. Leibel R, Chung W, Chua S Jr: The molecular genetics of rodent single gene obesities. J Biol Chem 1997, 272:31937-31940.
20. Gerich J: The genetic basis of type II diabetes mellitus: impaired insulin sensitivity versus impaired insulin sensitivity. Endocr Rev 1998, 19:491-503.
21. Cefalu W: Insulin resistance: cellular and clinical concepts. Exp Biol Med 2001, 226:13-26.
22. Shimabukuro M, Ahou y, Levi M, Unger RL: Fatty acid-induced B-cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 1998, 95:2498-2502.
23. Unger RL, Zhou Y: Lipotoxicity of B-cells in obesity and in other causes of fatty acid spillover. Diabetes 2001, 50:118-121.
24. Garris DR: Ovarian follicular lipoapoptosis: structural, cytochemical, and metabolic basis of reproductive tract atrophy following expression of the hypogonadal diabetes (db/db) syndrome. Reprod Toxicol 2005, 20:31-38.
25. Garris D, Garris B, Novikova L, Lau YS: Structural, metabolic, and endocrine analysis of the diabetes (db/db) hypogonadal syndrome: relationship to hypophyseal hypercytolipidemia. Cell Tiss Res 2005, 319:501-512.
26. Garris DR, Garris BL: Hypercytolipidemia promotes diabetes (db/db) mutations-associated utero-ovarian involution: counter-regulatory influences of progesterone. Pathophys 2004, 11:41-50.
27. Garris DR: Cytochemical analysis of pancreatic islet lipoapoptosis: hypercytolipidemia-induced cytoinvolution following expression of the diabetes (db/db) mutation. Pathobiol 2005, 72:124-132.
28. Garris DR, Garris BL: Diabetes-induced, progressive endometrial involution: characterization of periluminal epithelial lipoatrophy. Diabetes 2003, 52:51-58.
29. Garris DR, Garris BL: Diabetes (db/db) mutation-induced ovarian involution: progressive hypercytolipidemia. Exptl Biol Med 2003, 228:1040-1050.
30. Garris BL, Novikova L, Lau Y-S, Garris DR: Hypophyseal Lipoapoptosis: Diabetes (db/db) Mutation-Associated Cytolipidemia Promotes Pituitary Cellular Disruption and Dysfunction. Pituitary 2004, 7:5-14.
31. Krakauer J, McKenna M, Buderer N, Rao D, Whitehouse F, Parfitt A: Bone loss and bone turnover in diabetes. Diabetes 1995, 44:775-782.
32. Haffner S, Bauer R: The association of obesity and glucose and insulin concentrations with bone density in premenopausal and post-menopausal women. Metabolism 1993, 42:735-738.
33. Weinstock R, Goland R, Shane E, Clemens T, Lindsay R, Bilezikian J: Bone mineral density in women with type II diabetes mellitus. J Bone Min Res 1989, 4:97-101.
34. Tuominen J, Impivaara O, Puukka P, Ronnemaa T: Bone mineral density in patients with type 1 and type 2 diaetes. Diabet Care 1999, 22:1196-1200.
35. Nicodemus K, Folsom A: Type 1 and type 2 diabetes and incident hip fractures in post-menopausal women. Diabet Care 2001, 24:1192-1197.
36. Kayath M, Dib S, Viciaa J: Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitus. J Diab Compl 1994, 8:97-104.
37. Mathiassen B, Nielsen S, Ditzel J, Rodbro P: Long-term bone loss in insulin-dependent diabetes mellitus. J Int Med 1990, 227:325-327.
38. Loder R: The influence of diabetes mellitus on the healing of closed fractures. Clin Orthoped 1988, 232:210-216.
39. Yeh J, Aloia J, Barilla ML: Effects of 17B-estradiol replacement and treadmill exercise on vertebral and femoral bones of the ovariectomized rat. Bone Min 1994, 24:223-234.
40. Hough S, Avioli LV, Bergfeld MA, Fallon MD, Slatopolsky E, Teitelbaum SL: Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy. Endocr 1981, 108:2228-2234.
41. Garris DR: Reproductive tract and pancreatic norepinephrine levels in pre- and overt-diabetic C57BL/KsJ mice: relationship to body weight, blood glucose, serum insulin, and reproductive dysfunction. Proc Soc Exp Biol Med 1988, 189:79-83.
42. Garris DR: Diabetes-associated alteration in uterine structure in the C57BL/KsJ mouse: relationship to changes in estradiol accumulation, circulating ovarian steroid levels and age. Anat Rec 1985, 211:414-419.
43. Like A, Lavine R, Peffenberger P, Chick W: Studies in the diabetes mouse, IV: evaluation of glomerula lesions and associated proteinuria. Am J Pathol 1972, 66:193-224.
44. Bray G, York D: Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 1979, 59:719-809.
45. Garris DR: Morphometric analysis of obesity (ob/ob) and diabetes (db/db) associated hypothalamic neuronal degeneration in C57BL/KsJ mice. Brain Res 1989, 501:162-170.
46. Garris DR: Age and diabetes-associated alterations in regional brain norepinephrine concentrations and adrenergic receptor populations in C57BL/KsJ mice. Dev Brain Res 1990, 51:161-166.
47. Garris DR, Coleman DL: Diabetes-associated changes in estradiol accumulation in the aging C57BL/KsJ mouse brain. Neurosci Lett 1985, 49:285-290.
48. Garris DR: Developmental and regional changes in brain norepinephrine levels in diabetic C57BL/KsJ mice: effects of estradiol and progesterone. Dev Brain Res 1985, 89:314-319.
49. Garris DR: Estrogenic stimulation of hypothalamic-limbic system metabolism in ageing diabetic C57BL/KsJ mice. Neuroendocr 1999, 69:424-429.
50. Selby P: Osteopenia and diabetes. Diabet Med 1988, 5:423-428.
51. Johnston CC, Hui SL, Witt RM, Appledorn R, Baker RS, Lonccope C: Early menopausal changes in bone mass and sex steroids. J Clin Endocr Metabol 1985, 61:905-911.
52. Cauley J, Robbins J, Chen Z, Cummings S, Jackson R, LaCroix A, LeBoff M, Lewis C, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts N: Effects of estrogen plus progestin on risk of fracture and bone mineral density: the women's health initiative randomized trial. JAMA 2003, 290:1729-1738.